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Role for Aldosterone in Blood Pressure Regulation 
of Obese Adolescents 
ALBERT P. ROCCHINI, MD, VICTOR L. KATCH, EdD, ROGER GREKIN, MD, 
CATHERINE MOOREHEAD, BS, and JUDITH ANDERSON, PhD 
To determine the role of aldosterone in the regula- 
tion of blood pressure (BP) in obese adolescents, 
supine and P-hour upright plasma renin activity 
(PRA), and aldosterone and cortisol were measured 
in 10 nonobese and 30 obese adolescents before 
and after a 20-week weight loss program. The 
obese adolescents had significantly higher supine 
and 2-hour upright plasma aldosterone concentra- 
tions (17 f 8 vs 8 f 2 ng/dl [p <O.Ol supine 
obese vs nonobese] and 30 f 11 vs 14 f 8 ng/dl 
[p <O.Ol 2-hour upright]). Although PRA was not 
significantly different between the 2 groups of chil- 
dren, a given increment in PRA produced a greater 
increment in aldosterone in the obese adolescents. 
In addition, obese subjects had a significantly in- 
creased mean BP (93 f 12 vs 74 f 8, p <0.005) 
and a weak correlation between BP and plasma ai- 
dosterone concentration. Compared wlth an obese 
control group, weight loss resulted in a significant 
decrease in plasma aldosterone (p <O.Ol) without 
an associated decrease in PRA. After weight loss 
there was also a significant decrease in the slope of 
the posture-induced relation between PRA and aldo- 
sterone. In addition to weight loss being associated 
with a significant decrease in BP (p <O.Ol), there 
was a significant correlation between the change in 
plasma aldosterone and the change in mean BP (r 
= 0.538; p <0.002 change in upright aldosterone 
vs change in mean BP). Obese adolescents have 
an increased plasma aldosterone concentration that 
may be important in the regulation of their BP. 
(Am J Cardiol 1988;57:813-818) 
S ince 1924 it has been known that body weight and 
arterial pressure are related. However, little is known 
about the mechanism of this relation1 One physiologic 
change that may be partially responsible for hyperten- 
sion in the obese person is excess mineral corticoid 
activity. Scavo et a12v3 reported that although obese 
adults have normal plasma renin activity [PRA), they 
have an increased plasma aldosterone concentration 
and an increased aldosterone secretion rate. In obese 
adults with essential hypertension, Hiramatsu et al4 
documented that with increasing body weight PRA 
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decreases and plasma aldosterone concentration re- 
mains unchanged. Tuck et al5 demonstrated that with 
weight loss both PRA and plasma aldosterone concen- 
tration decrease. Although these and other observa- 
tions 6*7 suggest that in obese subjects abnormalities in 
the renin-aldosterone axis are present, the effect of 
these abnormalities on blood pressure [BP) is unclear. 
Therefore, we evaluated the role of aldosterone in the 
regulation of BP in 30 obese adolescents before and 
after a 20-week weight loss program. 
Methods 
Thirty obese adolescents, mean age 12.7 years 
[range 10 to 15), and 10 nonobese adolescents, mean 
age 12.2 years (range 10 to 14) were studied. Obesity 
was defined as weight for height above the 75th per- 
centile for age and sex and triceps and subscapular 
skin folds above the 80th percentile for age and sex. 
The obese subjects were randomly placed into 1 of 3 
groups. Group I consisted of 10 obese adolescents 
placed in a weight loss program composed of diet and 
behavior change. The diet was a modification of the 
caloric exchange program and was designed to pro- 
duce approximately,1 pound per week of weight loss 
613 
614 PLASMA ALDOSTERONE IN OBESE ADOLESCENTS 
TABLE I Pertinent Clinical, Hemodynamic and Electrolyte Data 
in 30 Obese and 10 Nonobese Adolescents 
Obese Nonobese 
(n = 30) (n = 10) p Value 
Age W 12.7 f 2.2 12.2 f 3.0 NS 
Weight (kg) 75.8 f 22 42.2 f 13 p <o.ooi 
% fat 40 f 6 20 f 7 p <O.OOl 
Mean BP (mm Hg) 93f 12 74 f 8 p <0.005 
HR (beats/min) 86 f 12 77 f 6 p <0.05 
Kf (mEq/liter) 4.0 f 0.2 4.3 f 0.2 p (0.03 
NA+ (mEq/liier) 142 f: 2 138 f 3 p <0.03 
UNa (mEq124 hr) 212 f 77 136 f 14 p <0.02 
BP = blood pressure; HR = heart rate: NS = not significant; LJNa A urinary 
sodium excretion. 
(1,200 to 1,800 calories/day). The behavior change 
component consisted of a l-hour class each week for 
20 weeks that centered around record keeping, stimu- 
lus control, changing eating typography, and rein- 
forcement of altered behavior. Group II consisted of 10 
obese adolescents placed in a weight loss program 
consisting of diet, behavior change and exercise. The 
diet and behavior change were the same as in group I. 
The exercise program consisted of three l-hour classes 
per week for 20 weeks, centering around activities de- 
signed to maintain heart rate for at least 40 minutes at 
more than 50% of maximal exercise rate. Group III 
consisted of 10 obese adolescents placed in a control 
group who received no weight loss program for 20 
weeks. All 30 obese subjects were tested before and 
after the 20 weeks, The 10 nonobese adolescents were 
tested only once. 
Experimental protocol: All patients were admitted 
overnight to the Clinical Research Center. BP was 
measured every 5 minutes for 30 minutes in a quiet 
room using a Critikon pressure monitor (model 11651 
and an appropriate-size cuff. Mean BP was calculated 
as diastolic pressure plus one-third pulse pressure. All 
patients fasted after 10 PM of the evening preceding the 
study and were maintained in a supine position after 4 
AM on the morning of the study. A heparin lock was 
placed at 7:3O AM, and with the patient in the supine 
position, blood was obtained for PRA, plasma aldoste- 
rone, plasma cortisol, serum sodium and potassium. 
After being upright and ambulating for 2 hours, repeat 
blood samples were obtained. Dietary sodium intake 
was assessed in all patients by measuring the Z&hour 
urinary sodium excretion the day before the study. 
Laboratory procedures: Weight was measured us- 
ing a beam balance scale and height was measured to 
the nearest 0.1 cm using a stabilometer. Body composi- 
tion (percent fat and lean body weight) was measured 
by hydrostatic weighing.* Sodium concentration was 
determined by flame photometry. Aldosterone, corti- 
sol and PRA were measured by radioimmunoassay.g-*l 
Statistical analysis: Statistical analysis was per- 
formed using analysis of variance to compare differ- 
ences between the nonobese and obese adolescents. 
To compare differences between the 3 obese groups 
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FIGURE 1. Supine and P-hour upright plasma aldo- 
sterone concentration, plasma renln activity and 
plasma cortisol concentration In 30 obese and 10 
nonobese adolescents. SD = standard deviation. 
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TABLE II Change in Body Composition, Blood Pressure, Aldosterone, plasma Renin ctivity arid Electrolytes After 
Weight Loss Program or Control Period 
___- 
Obese Control Obese Diet Obese Diet i- Exercise 
(n = 10) (n = 10) (n = IO) 














Serum Na+ (mEq/liter) 
Serum K+ (mEq/liter) 
UNaf (mEq/24 hr) 
24-hr urine Great. (g/day) 
67.6 f 30 
39 f 6 
157 f 9 
88f 10 
21 f 15 
29 f 8 
1.9 f 1.2 
4.9 f 1.7 
19 f 4 
14 f 4 
142 4~ 2 
4.0 f 0.2 
211 f 74 
1.1 f 0.4 
71.9 f 25 
41 f9 
161 f IOt 
93f 13 
18 f 6 
31 f7 
1.7 f 1.1 
3.8 f 1.3 
19 f 4 
14 f 4 
142 f 2’t 
3.9 f 0.2 
194 f 62 
1.2 f 0.3 
72.4 f 20 
41&7 
157 f 10 
92& 12 
15 * a 
28 f 8 
1.4 f 0.8 
3.8 f 1.8 
19 f 5 
15f3 
142 f 3 
3.9 -I: 0.25 
212 f 57 
1.2 f 0.3 
69.9 f 17* 
36 f 7tt 
161 -+ Qt 
81 f 7tt 
10 f 6tt 
19 f 6tt 
1.6 f 0.9 
4.9 f 1.5 
15 f 3’5 
12 f 3’9 
140 f 2’5 
4.2 f 0.2’9 
184 f 33 
1.2 -I 0.3 
71 f8 
40 f 6 
157 f 6 
90 f a 
17 f a 
38f 12 
1.6 f 0.95 
5.1 f 2.1 
18 f 4 
16f3 
142 f 2 
3.9 f 0.2 
208 I 78 
1.2 rt 0.2 
69 f 9+t 
34 f 5tt 
162 f 6t 
82 f 4tt 
9 f 4tz 
19 ?c 4+t 
2.4 f 0.9 
4.9 dx 1.6 
15 f 2’§ 
12 f 2’5 
140 f 2’6 
4.2 2~ 0.3’5 
195 f 77 
1.2 f 0.3 
Pre vs post: l p <0.05; 7 p <O.Ol; obese control vs obese diet or diet + exercise; t p <O.Oi; 5 p <0.05. 
Aldo = aldosterone; BP = mean blood pressure; Creat. = creatinine; UNa = urinary sodium excretion; Kt = potassium; Na + = sodium: pre = before weight 
loss; post = after 20-week weight loss program or control period; PRA = plasma renin activity. 
3 analysis of variance and the Scheffe12 procedure for 
multiple comparisons. 
Systolic and diastolic BPS were adjusted for age and 
sex by use of the standard deviation score (z) calculat- 
ed according to the formula z = x-x/SDx, where x = 
measured BP, x = mean of the expected BP for age and 
sex (Hanes II datals), and SDx = standard deviation x. 
Linear regression analysis was used to determine the 
correlation between posture-induced changes in PRA 
and plasma aldosterone in nonobese and obese ado- 
lescents before and after weight loss. Comparisons be- 
tween regression slopes were made using analysis of 
variance. The homogeneity of variance was assessed 
by Bartlett’s test.14 All results are expressed as mean f 
standard deviation. 
Results 
Compared with the 10 nonobese adolescents, the 30 
obese adolescents had a higher mean BP (p <O.O05] 
(Table I). They also had an increased 24-hour urinary 
sodium excretion rate (p <O.O2] and serum sodium 
concentration (p <O.O3) and a decreased serum potas- 
sium concentration (p <O.O3). The association of an 
elevated mean BP, a mildly decreased serum potassi- 
um concentration and a mildly increased serum sodi- 
um concentration in our obese adolescents is consis- 
tent with the possibility of an excess in mineral 
corticoid activity. 
To evaluate the renin-angiotensin-aldosterone axis 
in adolescent obesity, we compared the changes in 
PRA and aldosterone concentration that occurred with 
acute postural change. Compared with nonobese ado- 
lescents, the obese adolescents had an elevated plas- 
ma aldosterone concentration in both the supine (17 f 
8 vs 6 f 2 ng/dl, p <O.Ol) and upright (30 f 11 vs 14 f 8 
ng/dl, p <O.Ol) positions (Fig. I]. However, despite the 
observed increase in plasma aldosterone, the 2 groups 
of children had similar changes in PRA. 
Because BP in childhood is affected by both age 
and sex, in order to evaluate the relation between plas- 
ma aldosterone concentration and BP, a Z score BP 
was determined for each adolescent. In the obese ado- 
lescents, there were correlations between both Z score 
systolic and diastolic BP and a-hour upright plasma 
aldosterone concentration (r = 0.35 and 0.56, respec- 
tively, p <0.05), fat weight (r = 0.35 and 0.56, respec- 
tively, p <0.05) and plasma potassium concentration (r 
= 0.42, p <0.05 for diastolic BP]. The effect of weight 
loss on these variables was evaluated by comparing 
the changes in plasma aldosterone, PRA, plasma corti- 
sol, serum sodium and potassium, body weight, fat 
weight and BP that occurred in 2 groups of obese ado- 
lescents after 20 weeks of weight loss vs that which 
occurred in a group of obese adolescents after a 2% 
week control period. 
The two 20-week weight loss groups showed mod- 
est but significant decreases in body weight (p <O.(Bl). 
In fact, all patients in the weight loss programs lost 
some weight, whereas all of the obese control patients 
gained weight. Since both the obese control group and 
weight loss groups had a significant 4-cm increase in 
height (p <O.Ol), the modest decrease in body weight 
observed in the 2 weight loss groups was associated 
with marked changes in body composition (Table II]. 
In addition, compared with the obese control subjects, 
the 2 weight loss groups had a significant decrease in 
fat weight (p <O.Ol), mean BP (p <O.Ol), supine and 
upright plasma aldosterone (p <O.Ol), plasma cortisol 
(p <0X13) and serum sodium concentration (p <O.O2), 
and a small but significant increase in serum potassi- 
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urn concentration [p <O.OZ) (Table II]. The decrease in 
mean BP during the 20-week program significantly 
correlated with the change in plas,ma aldosterone [r = 
0.38, p <0.03 supine and r = 0.54, p <0.002 upright) 
[Fig. 21, fat weight [r = 0.73, p <O.OOlj, and body weight 
(r = 0.60, p <O.Ol). Th e c h anges in plasma aldosterone 
and changes in body weight and fat weight were sig- 
nificantly correlated (r = 0.421, p X0.05 and r = 0.61, p 
<O.Ol, respectively). There was also a significant cor- 
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sterone independent of the effect of body weight (p = 
0.05). 
Although weight loss was associated with a signifi- 
cant decrease in plasma aldosterone concentration, 
we observed no significant change in PRA. However, 
weight loss markedly affected the relation between the 
posture-induced changes in PRA and plasma aldoste- 
rone. Before weight loss, the increment in plasma 
aldosterone between supine and upright posture di- 
vided by the increment in PRA was significantly in- 













-394 -32.9 -264 -199 -134 -6.0 -.X7 62 12.7 19.2 
FIGURE 2. Regression relation between the change in mean arterial pressure (MAP) and the change in plasma aldosterone concentration 
during the 20-week study. 
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FIGURE 3. Regression relations between posture-induced changes in plasma renln activity’ and plasma aldosterone in IO obese control 
subjects (dots), in 20 obese subjects afler weight loss (circles) and in 10 nonobese subjects (squares). The 2 weight-loss groups were 
combined. 
March 1, 
creased in the obese adolescents (1.8 vs 4.4 ng/dl al- 
dosterone/ng/ml/hour AI, p <O.Ol nonobese vs obese 
adolescents]. After the weight loss program, there was 
a significant decrease in the slope of the relation be- 
tween PRA and aldosterone to the extent that only the 
obese control group still had a slope that was signifi- 
cantly greater than the nonobese adolescents (Fig. 31. 
Discussion 
In the present study, we have demonstrated that 
compared with nonobese adolescents, obese adoles- 
cents have a significantly higher plasma aldosterone 
concentration. Other investigators have also demon- 
strated abnormal aldosterone production in obesity. 
Garnett et al6 documented a mild increase in aldoste- 
rone secretion in 9 obese adults. In addition, Scavo et 
aP3 demonstrated that in obese adults aldosterone se- 
cretion is significantly increased in both absolute val- 
ues as well as when indexed to body surface area, the 
metabolic clearance rate of aldosterone is normal and 
the plasma aldosterone concentration is increased. 
However, unlike Scavo’s study, in the present study, 
we also evaluated both the effect of weight loss on the 
hyperaldosteronism of obesity and the correlation be- 
tween the increased plasma aldosterone concentration 
and BP. We observed that weight loss, either with or 
without exercise, produced a significant reduction in 
both plasma aldosterone concentration and BP and a 
small but significant increase in serum potassium con- 
centration. In addition, the decrease in plasma aldo- 
sterone concentration significantly correlated with the 
observed decrease in mean BP. Thus, our data suggest, 
but do not prove, that the hyperaldosteronism associ- 
ated with obesity may have contributed, in part, to the 
hypertension of obesity. Tuck et al5 demonstrated, as 
did we, that with weight loss, plasma aldosterone lev- 
els decrease while serum potassium concentration in- 
creases. However, unlike our study, Tuck did not dem- 
onstrate a statistically significant correlation between 
the decrease in aldosterone concentration and the de- 
crease in mean BP. A possible explanation for the 
differences between the 2 studies may be that Tuck et 
al severely reduced caloric intake to 320 kcal/day [al- 
most starvation levels], whereas in the present study, 
only a mild reduction in caloric intake was used. Since 
Spark et al7 and Garnett et al6 demonstrated that with 
fasting wide swings in both aldosterone and PRA can 
occur, it is possible that these starvation-induced 
swings in aldosterone may have obscured the correla- 
tion between changes in plasma aldosterone and 
changes in mean BP. 
The mechanism of hyperaldosteronism of obesity is 
unknown. Although aldosterone metabolism was not 
measured in this study, on the basis of the work of 
Scavo et a12v3 and Garnett et aL6 the hyperaldosteron- 
ism observed in our obese adolescents was probably a 
result of increased aldosterone secretion rather than 
decreased metabolic clearance. Aldosterone secretion 
is normally regulated by the renin-angiotensin system, 
serum potassium,15 sodium balance,16 ACTH activi- 
ty 17*18 and other less defined secretagogues.lg Our data 
suggest that the hyperaldosteronism of obesity may be 
the result of an abnormality either in the renin-angio- 
tensin system or in ACTH activity, With regard to the 
renin-angiotensin system, even though angiotensin II 
was not directly measured because PRA was normal 
and was not altered by weight loss, it is unlikely that an 
increase in plasma angiotensin II was present. How- 
ever, based on the observation that a given increment 
in PRA produced a greater increment in aldosterone in 
the obese adolescents and that weight loss, in part, 
corrected this relation, adrenal sensitivity to angioten- 
sin II may apparently be increased.2’J Hiramatsu et al4 
also observed that obese patients have an increased 
aldosterone/PRA ratio. Kisch et a121 and Marks et a1,22 
using a graded infusion of angiotensin II, demon- 
strated that some patients with essential hypertension 
have increased adrenal sensitivity to angiotensin II. 
Many of Kisch’s hypertensive patients may have been 
mildly obese. Since Shoback et a123 reported that a 
substantial subgroup of essential hypertensive patients 
have an abnormality in sodium-modulated renovascu- 
lar and adrenal responsiveness to angiotensin II, our 
results suggest that a similar defect may also be present 
in obese adolescents. Further studies in obese adoles- 
cents before and after weight loss, using graded infu- 
sions of angiotensin II, are required to prove that obe- 
sity can produce a defect in tissue responsiveness to 
angiotensin II. 
Finally, although we did not directly measure 
ACTH activity since weight loss was associated with a 
significant decrease in serum cortisol, it is possible that 
ACTH activity could have also decreased. Other in- 
vestigators also demonstrated an increased cortisol ex- 
cretion rate in obesity24,25; increased ACTH activity 
may also contribute to the hyperaldosteronism of 
obesity. 
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